An ambitious partnership between the Dielen Laboratory, the University of Lille, the Institut Pasteur de Lille, and Algaia.
The objective: to develop new algae-based health active ingredients, bridging the gap between dietary supplements and pharmaceuticals.
This project draws on the Dielen Laboratory’s unique expertise in marine bioactivity and the scientific complementarity of the partners involved.
The kick-off meeting was held at the end of July in Cherbourg-en-Cotentin, with Benoît Queguineur, Aurélie Préchoux, Adrien Noël, Paul Violette, Rozenn Ravallec, and Christophe Flahaut in attendance.
With a total budget of €2.8 million, including €1.7 million funded by the France 2030 plan, ActivAlgues is paving the way for a new generation of innovative and sustainable health solutions.
A concrete project, at the intersection of science and innovation, to transform research into real health benefits.
To be continued…